Radiopharm Theranostics RADX
NASDAQ RADX
$1.42 -0.06 (-4.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Selling, General & Administrative (2023 - 2026)

Updated

Radiopharm Theranostics (RADX) recorded Selling, General & Administrative of -$110,131 in FY2026 (year ended Jun 30, 2026), compared with -$14.64 million in FY2025.

Analysis

Radiopharm Theranostics (RADX) Selling, General & Administrative (2023 - 2026) Analysis & Trends

Starting with FY2023, Radiopharm Theranostics' Selling, General & Administrative history includes 4 fiscal years.

  • Per Business Quant data, RADX's Selling, General & Administrative was -$14.64 million in FY2025, -$13.04 million in FY2024 and -$12.23 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Radiopharm Theranostics 5.25 Bn 5.21 Bn 186,835.86 -11.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.50 Mn
Jun 30, 2025 -14.64 Mn
Jun 30, 2024 -13.04 Mn
Jun 30, 2023 -12.23 Mn
API Access

Radiopharm Theranostics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RADX&period=max&api_key=YOUR_API_KEY